Product NDC: | 59390-140 |
Proprietary Name: | Ofloxacin ophthalmic |
Non Proprietary Name: | Ofloxacin |
Active Ingredient(s): | 3 mg/mL & nbsp; Ofloxacin |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59390-140 |
Labeler Name: | Altaire Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202692 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130531 |
Package NDC: | 59390-140-05 |
Package Description: | 5 mL in 1 BOTTLE, DROPPER (59390-140-05) |
NDC Code | 59390-140-05 |
Proprietary Name | Ofloxacin ophthalmic |
Package Description | 5 mL in 1 BOTTLE, DROPPER (59390-140-05) |
Product NDC | 59390-140 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ofloxacin |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20130531 |
Marketing Category Name | ANDA |
Labeler Name | Altaire Pharmaceuticals Inc. |
Substance Name | OFLOXACIN |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |